Johannes Fruehauf
Investor and Board Member @Zag Bio
Signup · Get unlimited contacts
WORK HISTORY
Investor and Board Member @Zag Bio
Zag Bio is a developing targeted immunotherapy for autoimmune diseases by inducing central (thymic) tolerance.
EDUCATION
Goethe University Frankfurt
MD, Medicine
SLP Boston 2012
Fellow, Entrepreneurship/Entrepreneurial Studies
Harvard Medical School
Postdoc, Molecular Biology
University of Montpellier
Medicine
SKILLS
ABOUT JOHANNES FRUEHAUF
Biotech entrepreneur and investor with a track record of building and growing successful companies and research ecosystems. Physician-scientist experienced in the development of complex biologics programs from bench into the clinic, including the first ever oral RNAi drug to enter the clinic. Co-founder and General Partner at MissionBioCapital. Founder & CEO of Biolabs/LabCentral, with locations in Cambridge, Boston, Durham, Philadelphia, San Diego, New York, Princeton, Los Angeles, Dallas, New Haven, Tokyo, Paris and Heidelberg. Specialties: Company building, Structure of Innovation, Venture Capital, Biologics development, translational science, clinical trials, drug delivery, oligonucleotide therapeutics, startup financing, preclinical and clinical development, technology licensing and development, entrepreneurship, international relations.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.